BMY Bristol Myers Squibb
$59.59 +1.33%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+1.33%
YTD
+33.40%
P/E
13.41
P/B
5.94
ROE
46.8%
Div yield
4.6%
Beta
0.22
Market cap
$124.5B
RSI (14)
35
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$58.94
Close
$59.59
VWAP (n/a)
—
Day high
$59.60
Day low
$58.64
Volume
9.9M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Sotyktu Gains Ground in Psoriatic Arthritis, but Rheumatologists Remain Selective as Its Role in the Treatment Algorithm Takes Shape, According to Spherix Global Insights
Yahoo Finance · Oct 6
Zacks.com featured highlights Dollar General, Bristol-Myers Squibb and Equinor ASA
Yahoo Finance · Oct 6
Bristol Myers (BMY) Stock is Trading Below 10 Times Forward Earnings. Here’s Why it Matters
Yahoo Finance · Oct 5
BMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance · Oct 5
Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?
Yahoo Finance · Oct 5
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement
Yahoo Finance · Oct 5
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View → 8-K May 8, 2026 View → 10-Q Apr 30, 2026 View → 8-K Apr 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BMY. Try it in the Lab to size a position and see the risk.